Jakie leki stosuje się w profilaktyce choroby meningokokowej?

Patrz tabela.

Jeżeli lek jest zarejestrowany do stosowania w profilaktyce poekspozycyjnej, to może być wypisany ze zniżką.

Piśmiennictwo

1. Albrecht P., Hryniewicz W., Kuch A. i wsp.: Rekomendacje postępowania w zakażeniach bakteryjnych ośrodkowego układu nerwowego. Warszawa 2011, 77–79
2. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC. Prevention and control of meningococcal disease. MMWR, 2013; 62 (RR-2): 1–22
3. Charakterystyka produktu leczniczego Nimenrix; www.ec.europa.eu
4. National Immunisation Advisory Committee (Ireland); www.immunisation.ie/en/Downloads/NIACGuidelines/PDFFile_15483_en.pdf
5. Immunisation against infectious disease. Green Book. www.dh.gov.uk
6. UPDATE: Invasive meningococcal disease in men who have sex with men. Four New Cases Reported in 2013, Expanded Vaccine Recommendations. www.nyc.gov/html/doh/downloads/pdf/cd/2013/13md05.pdf
7. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep., 2005; 54 (RR-7): 1–21. www.cdc.gov
8. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ, 2004; 328 (7452): 1339. www.ncbi.nlm.nih.gov
9. De Wals P., Hertoghe L., Borlee-Grimee I. i wsp.: Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts. J. Infect., 1981; 3 (supl.): 53–61
10. Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. The meningococcal disease surveillance group. J. Infect. Dis., 1976; 134: 201–204
11. Jacobson J.A., Filice G.A., Holloway J.T.: Meningococcal disease in day-care centers. Pediatrics, 1977; 59: 299–300
12. Canadian Immunization Guide. Meningococcal Vaccine. www.phac-aspc.gc.ca